Loading clinical trials...
Loading clinical trials...
Safety and Immunogenicity Study of an Additional Dose of HPV Vaccine (580299) in Young, Adult Women in North America.
Conditions
Interventions
Cervarix™
Locations
17
United States
GSK Investigational Site
San Francisco, California, United States
GSK Investigational Site
Augusta, Georgia, United States
GSK Investigational Site
Bardstown, Kentucky, United States
GSK Investigational Site
Louisville, Kentucky, United States
GSK Investigational Site
Albuquerque, New Mexico, United States
GSK Investigational Site
Portland, Oregon, United States
Start Date
January 14, 2008
Primary Completion Date
December 22, 2008
Completion Date
December 1, 2009
Last Updated
June 26, 2018
NCT01627561
NCT00196937
NCT01462357
NCT01190176
NCT01277042
NCT00345878
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions